Treatment patterns, healthcare resource utilization, and healthcare costs among patients with pulmonary arterial hypertension in a real‐world US database-Reference-Cited by-同舟云学术

Treatment patterns, healthcare resource utilization, and healthcare costs among patients with pulmonary arterial hypertension in a real‐world US database

Published:2018-12 Issue:1 Volume:9 Page:1-12
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

Studer Sean¹,Hull Michael²,Pruett Janis³,Koep Eleena²,Tsang Yuen³,Drake William³

Affiliation:

1. NYC Health + Hospitals/Kings CountyNew YorkNYUSA

2. OptumEden PrairieMNUSA

3. Actelion Pharmaceuticals US, Inc.South San FranciscoCAUSA

Funder

Actelion Pharmaceuticals

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/2045894018816294

Reference45 articles.

1. Sanchez MA, et al. Diagnosis and assessment of pulmonary arterial hypertension;Badesch DB;J Am Coll Cardiol,2009

2. Updated clinical classification of pulmonary hypertension;Simonneau G;J Am Coll Cardiol,2013

3. The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non‐US Contemporary Registries;Frost AE;Chest,2011

4. Treatment patterns and resource utilization and costs among patients with pulmonary arterial hypertension in the United States;Angalakuditi M;J Med Econ,2010

5. Changes in healthcare utilization and costs associated with sildenafil therapy for pulmonary arterial hypertension: a retrospective cohort study;Berger A;BMC Pulm Med,2012

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of pulmonary hypertension in special conditions;European Respiratory Journal;2024-08-29

2. Medication adherence, related factors and outcomes among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: a systematic review;European Respiratory Review;2024-07

3. Treatment patterns and factors associated with adherence in pulmonary arterial hypertension;Farmacia Hospitalaria;2024-07

4. Comparative adherence of macitentan versus ambrisentan and bosentan in Australian patients with pulmonary arterial hypertension: a retrospective real-world database study;Journal of Medical Economics;2024-04-10

5. Factors associated with discontinuation of treatment for pulmonary arterial hypertension in the United States;Pulmonary Circulation;2024-04